Funds holding Quince Therapeutics Inc
ISIN US22053A2069 · United States
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 719.2 $
- Share of capital
- 0.1 % of 1M shares on Aug 7, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Victory Extended Market Index Fund Victory Portfolios III | 549 | 719.2 $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
Institutional managers
6 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Gen-Wealth Partners Inc | 33,018 | 3.3K $ | as of Mar 31, 2026 |
| Catalyst Funds Management Pty Ltd | 30,000 | 3K $ | as of Mar 31, 2026 |
| Fortitude Family Office, LLC | 8,095 | 821 $ | as of Mar 31, 2026 |
| Advisory Services Network, LLC | 5,500 | 558 $ | as of Mar 31, 2026 |
| Parallel Advisors, LLC | 795 | 81 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 135 | 14 $ | as of Mar 31, 2026 |
Declared shareholders of Quince Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Integrated Core Strategies (US) LLC and 3 others | 7.20 % | 1,403,697 | as of Jun 4, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Quince Therapeutics Inc". https://titelia.com/en/stocks/quince-therapeutics-inc-US22053A2069